MedTrace Logo

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

NCT07160036 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-09-15

No results posted yet for this study

Summary

To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment

Conditions

  • Myopia

Interventions

DEVICE

RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))

use RLRL twice a day

Sponsors & Collaborators

  • Tianjin Medical University Eye Hospital

    collaborator OTHER

  • Ruihua Wei

    lead OTHER

Principal Investigators

  • Ruihua Wei · Tianjin Medical University Eye Hospital, Tianjin, Tianjin 120120 Recruiting

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-20
Primary Completion
2025-11-20
Completion
2025-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160036 on ClinicalTrials.gov